The research was done by infection control experts at Rochester General Hospital in Rochester, N.Y., who are on the faculty at the University of Rochester Medical Center.
"I was pleasantly surprised by the results," said Ann Falsey, M.D., who led the study. "Rapid testing does give physicians evidence to discontinue antibiotics, and some physicians are responding to the evidence.
Falsey's team analyzed the records of 166 patients who definitely had the flu when hospitalized. Eighty-six of the patients tested positive with the rapid test, which gives an answer within minutes, while the 80 others either did not have the rapid test done, or they tested negative at the time but were later found to have the flu. The team checked the subsequent treatment to see if there was a difference in the use of antibiotics, which aren't effective or useful against viruses like the flu.
They found that 86 percent of the patients whose flu was confirmed early on were treated with antibiotics, compared to 99 percent of the patients whose flu wasn't identified immediately. It's not a huge difference in numbers, but the study showed that the difference is significant, demonstrating that the rapid test does reduce the use of antibiotics in the hospital.
"At least some proportion of doctors is willing to stop antibiotics when patients have a documented viral infection," said Falsey. "This is certainly encouraging, but there is a lot more work to do."
The issue is important, says Falsey, because the over-use of antibiotics makes patients and the community more vulnerable to dangerous microbes resistant to most treatments. It's particularly important in hospitals, where people most prone to infection are treated.
Yet, Falsey noted in the study that 61 percent of patients who were generally at low risk for bacterial infection continued to receive antibiotics. She says that the prescription of antibiotics to patients with a viral infection is often done by doctors who believe that their patient may also have a bacterial infection or that antibiotics will prevent subsequent bacterial infections that could occur while the person is weak with the flu or another virus. In the current study, for instance, those patients with the flu who were still receiving antibiotics tended to be older, smokers, and have breathing difficulties. In other words, they were the ones most vulnerable to such an infection.
Nevertheless, Falsey notes that there have been no studies proving that such a practice is effective at preventing infections.
"Doctors are trying to do the right thing by their patients. Sometimes they perceive antibiotics as the safest choice, even though a virus may be the cause of their patient's illness," said Falsey, noting that 90 percent of people with the flu who see a doctor are given antibiotics, even though the drugs won't help.
The simplest solution to antibiotic resistance would be for doctors to not prescribe antibiotics when they're unlikely to help, such as when a patient definitely has the flu, the common cold, or most cases of sore throat. But when patients don't feel well, many march into their doctor's office expecting an answer and feel neglected if they don't receive a prescription in return for their visit. That leaves doctors caught between prescribing medication that probably won't help, vs. appearing unhelpful to their patients.
"Oftentimes people get sick, they just want to feel better, and they assume there is a pill that will make them better quickly," said Falsey. "Unfortunately, that's not the case for many respiratory illnesses that are caused by viruses. Instead they should rest, drink plenty of fluids, and take over-the-counter medications to help ease their symptoms. But many patients don't want to hear that, and it can be difficult for a doctor to deliver the news."
Tom Rickey | EurekAlert!
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences